Roundhill, E.A.; Pantziarka, P.; Liddle, D.E.; Shaw, L.A.; Albadrani, G.; Burchill, S.A.
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. Cancers 2023, 15, 769.
https://doi.org/10.3390/cancers15030769
AMA Style
Roundhill EA, Pantziarka P, Liddle DE, Shaw LA, Albadrani G, Burchill SA.
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. Cancers. 2023; 15(3):769.
https://doi.org/10.3390/cancers15030769
Chicago/Turabian Style
Roundhill, Elizabeth Ann, Pan Pantziarka, Danielle E. Liddle, Lucy A. Shaw, Ghadeer Albadrani, and Susan Ann Burchill.
2023. "Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates" Cancers 15, no. 3: 769.
https://doi.org/10.3390/cancers15030769
APA Style
Roundhill, E. A., Pantziarka, P., Liddle, D. E., Shaw, L. A., Albadrani, G., & Burchill, S. A.
(2023). Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. Cancers, 15(3), 769.
https://doi.org/10.3390/cancers15030769